Drug Monograph on Rifampicin - page 10
Keywords: rifampicin, drug monograph, pharmacology, efficay, therapeutic uses, pharmacodynamics, Prophylaxis of meningococcal meningitis rifampin rifadin SA infections tuberculosis essay on rifampicin pharmacokinetics absorption distribution matabolism excretion bmj referecing
By Einstein10 on 30/12/2009
Level: Foundation Degree
Page Number: 10 of 11 pages: 1 2 3 4 5 6 7 8 9 10 11
March 2009)
35. Andre E, Bastide L, Charachon M S, Gouby A, Guillot V, Latouche J, Bouchet A, Gualtie M, Leonetti J P. Novel synthetic molecules targeting the bacterial RNA polymerase assembly.JAS 2005;57:245-51
36. Burton F Z. Biochemistry and Molecular Biology. 2008. http://www.bch.msu.edu/faculty/burton.htm (accessed Mar 2009)
37. Page, C. Curtis, M. Sutter, M. Walker, M. Hoffman, B. Integrated Pharmacology. Second edition. New York City: Harcourt publishers, 2002
38. Sasaki. S, Takeshita F, Okuda K, Norishisa I. Mycobacterium Leprae and Leprosy. Microbiol Immunol.2001;45:729 (Leprsoy)
39. Wrong Diagnosis. Maltase Fever. http://www.wrongdiagnosis.com/medical/maltese_fever.htm (accessed April 2009)
40. Peloquin C. What is the ‘right’ dose of rifampin?. INT J TUBERC LUNG DIS 7.2003;3:3-5
41. O’Reilly, R.A.: Interaction of Sodium Warfarin and Rifampin. Studies in Man. Annals of Internal Medicine.1974;81:337-40
42. Thurmer A, Helbig JH, Jacob E, Kuck PC. PCR-based 'serotyping' of Legionella pneumophila. J Med Microbiol.2009;5:588-90
43. Infectious Disease Epidemiology Section .LEGIONELLA INFECTIONS. www.oph.dhh.state.la.us (accessed April 2009)
44. Shououpe D, Siri LK. Oral Contraceptives. Annals of J Med. 2005:145-52
Bibliography
44. Dollery, C. Therapeutic drugs. Second edition. Edinburgh: Churchill Livingstone, 1999:576-592
45. Katzung, BG. Basic and clinical pharmacology. Eighth edition international edition. USA: McGraw Hill companies, 2001
46. Campbell A, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst A S. Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase. Cell Press.2001;104:901-12
47. Hartmann R G, Heinrich P, Kollenda C M, Skrobranek B, Tropschug M, Weid W. Molecular Mechanism of Action of the Antibiotic Rifampicin. Angewandte Cheme. 1985; 24: 1009-74
48. Thomen P, Lopez J P, Heslot C F. Unravelling the mechanism of RNA-polymerase forward motion by using mechanical force. Laboratoire Pierre Aigrain.2004; 1: 1-4
49. British National Formulary. London: Pharmaceutical press, 2008
50. Sweetman, SC. Martindale: The complete drug reference. 35 edition. London: Pharmaceutical press, 2007
51. British National Formulary. London: Pharmaceutical press, 2008
52. Rifampin. 2009. http://www.merck.com/mmpe/lexicomp/rifampin.html (accessed Mar 2009)
53. Todar, K. The Microbial World. 2008. http://bioinfo.bact.wisc.edu/themicrobialworld/antimicrobial.html (accessed March 2009)
54. Andre E, Bastide L, Charachon M S, Gouby A, Guillot V, Latouche J, Bouchet A, Gualtie M, Leonetti J P. Novel synthetic molecules targeting the bacterial RNA polymerase assembly.JAS 2005;57:245-51
55. Burton F Z. Biochemistry and Molecular Biology. 2008. http://www.bch.msu.edu/faculty/burton.htm (accessed Mar 2009)
56. Page, C. Curtis, M. Sutter, M. Walker, M. Hoffman, B. Integrated Pharmacology. Second edition. (place of publish): Harcourt publishers, 2002
57. Sasaki. S, Takeshita F, Okuda K, Norishisa I. Mycobacterium Leprae and Leprosy. Microbiol Immunol.2001;45:729 (Leprsoy)
58. Wrong Diagnosis. Maltase Fever. http://www.wrongdiagnosis.com/medical/maltese_fever.htm (accessed April 2009)
59. Peloquin C. What is the ‘right’ dose of rifampin?. INT J TUBERC LUNG DIS 7.2003;3:3-5
60. Thurmer A, Helbig JH, Jacob E, Kuck PC. PCR-based 'serotyping' of Legionella pneumophila. J Med Microbiol.2009;5:588-90
61. Infectious Disease Epidemiology Section .LEGIONELLA INFECTIONS.
Last 5 comments…
There have been no comments posted for this article, but you need to register if you want to be the first!